Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects
Abstract
:1. Introduction
2. Sialic Acids in CoVs Infections
2.1. Sialic Acids–Structural and Functional Players in the Epidemiological Events
2.2. Coronavirinae-Obviousnesses and Surprises
2.3. MERS-CoV versus SARS-CoV—One Genus and Two Scenarios
2.4. SARS-CoV-2 versus SARS-CoV—Are Sialic Acids Really Important?
2.5. Does Siglec-Sialic Acid Axis Participates in CoVs Infections?
3. Conclusions and Perspectives
Author Contributions
Funding
Conflicts of Interest
References
- International Committee on Taxonomy of Viruses Executive Committee. The new scope of virus taxonomy: Partitioning the virosphere into 15 hierarchical ranks. Nat. Microbiol. 2020, 5, 668–674. [Google Scholar] [CrossRef]
- Pillaiyar, T.; Meenakshisundaram, S.; Manickam, M. Recent discovery and development of inhibitors targeting coronaviruses. Drug. Discov. Today 2020, 25, 668–688. [Google Scholar] [CrossRef]
- Tao, X.; Hill, T.E.; Morimoto, C.; Peters, C.J.; Ksiazek, T.G.; Tseng, C.T. Bilateral entry and release of Middle East respiratory syndrome coronavirus induces profound apoptosis of human bronchial epithelial cells. J. Virol. 2013, 87, 9953–9958. [Google Scholar] [CrossRef] [Green Version]
- Channappanavar, R.; Perlman, S. Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology. Semin. Immunopathol. 2017, 39, 529–539. [Google Scholar] [CrossRef]
- Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497–506. [Google Scholar] [CrossRef] [Green Version]
- Zhu, N.; Zhang, D.; Wang, W.; Li, X.; Yang, B.; Song, J.; Zhao, X.; Huang, B.; Shi, W.; Lu, R.; et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020, 382, 727–733. [Google Scholar] [CrossRef]
- Walls, A.C.; Park, Y.J.; Tortorici, M.A.; Wall, A.; McGuire, A.T.; Veesler, D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 2020, 181, 281–292. [Google Scholar] [CrossRef]
- Schwegmann-Wessels, C.; Herrler, G. Sialic acids as receptor determinants for coronaviruses. Glycoconj. J. 2006, 23, 51–58. [Google Scholar] [CrossRef]
- Harcourt, B.H.; Jukneliene, D.; Kanjanahaluethai, A.; Bechill, J.; Severson, K.M.; Smith, C.M.; Rota, P.A.; Baker, S.C. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J. Virol. 2004, 78, 13600–13612. [Google Scholar] [CrossRef] [Green Version]
- McBride, R.; van Zyl, M.; Fielding, B.C. The coronavirus nucleocapsid is a multifunctional protein. Viruses 2014, 6, 2991–3018. [Google Scholar] [CrossRef] [Green Version]
- Arndt, A.L.; Larson, B.J.; Hogue, B.G. A conserved domain in the coronavirus membrane protein tail is important for virus assembly. J. Virol. 2010, 84, 11418–11428. [Google Scholar] [CrossRef] [Green Version]
- Zeng, F.; Hon, C.C.; Yip, C.W.; Law, K.M.; Yeung, Y.S.; Chan, K.H.; Peiris, J.S.M.; Leung, F.C.C. Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: Implications for the functional roles of S2 subunit. FEBS Lett. 2006, 580, 5612–5620. [Google Scholar] [CrossRef] [Green Version]
- Wan, Y.; Shang, J.; Sun, S.; Tai, W.; Chen, J.; Geng, Q.; He, L.; Chen, Y.; Wu, J.; Shi, Z.; et al. Molecular mechanism for antibody-dependent enhancement of coronavirus entry. J. Virol. 2020, 94, e02015–e02019. [Google Scholar] [CrossRef] [Green Version]
- Matrosovich, M.; Herrler, G.; Klenk, H.D. Sialic acid receptors of viruses. Top. Curr. Chem. 2015, 367, 1–28. [Google Scholar] [CrossRef]
- Tortorici, M.A.; Walls, A.C.; Lang, Y.; Wang, C.; Li, Z.; Koerhuis, D.; Boons, G.-J.; Bosch, B.-J.; Rey, F.A.; de Groot, R.J.; et al. Structural basis for human coronavirus attachment to sialic acid receptors. Nat. Struct. Mol. Biol. 2019, 26, 481–489. [Google Scholar] [CrossRef] [Green Version]
- Qing, E.; Hantak, M.; Perlman, S.; Gallagher, T. Distinct roles for sialoside and protein receptors in coronavirus infection. mBio 2020, 11, e02764-19. [Google Scholar] [CrossRef] [Green Version]
- Schnaar, R.L. The biology of gangliosides. Adv. Carbohydr. Chem. Biochem. 2019, 76, 113–148. [Google Scholar] [CrossRef]
- Trinchera, M.; Aronica, A.; Dall’Olio, F. Selectin ligands sialyl-Lewis a and sialyl-Lewis x in gastrointestinal cancers. Biology 2017, 6, 16. [Google Scholar] [CrossRef]
- Bork, K.; Horstkorte, R.; Weidemann, W. Increasing the sialylation of therapeutic glycoproteins: The potential of the sialic acid biosynthetic pathway. J. Pharm. Sci. 2009, 98, 3499–3508. [Google Scholar] [CrossRef]
- Bas, M.; Terrier, A.; Jacque, E.; Dehenne, A.; Pochet-Béghin, V.; Beghin, C.; Dezetter, A.-S.; Dupont, G.; Engrand, A.; Beaufils, B.; et al. Fc sialylation prolongs serum half-life of therapeutic antibodies. J. Immunol. 2019, 202, 1582–1594. [Google Scholar] [CrossRef] [Green Version]
- Varki, A. Sialic acids in human health and disease. Trends Mol. Med. 2008, 14, 351–360. [Google Scholar] [CrossRef] [Green Version]
- Miyagi, T.; Takahashi, K.; Hata, K.; Shiozaki, K.; Yamaguchi, K. Sialidase significance for cancer progression. Glycoconj. J. 2012, 29, 567–577. [Google Scholar] [CrossRef]
- Vajaria, B.N.; Patel, K.R.; Begum, R.; Patel, P.S. Sialylation: An avenue to target cancer cells. Pathol. Oncol. Res. 2016, 22, 443–447. [Google Scholar] [CrossRef]
- Pearce, O.M.; Läubli, H. Sialic acids in cancer biology and immunity. Glycobiology 2016, 26, 111–128. [Google Scholar] [CrossRef] [Green Version]
- Chiodelli, P.; Urbinati, C.; Paiardi, G.; Monti, E.; Rusnati, M. Sialic acid as a target for the development of novel antiangiogenic strategies. Future Med. Chem. 2018, 10, 2835–2854. [Google Scholar] [CrossRef]
- McMillan, S.J.; Crocker, P.R. CD33-related sialic-acid-binding immunoglobulin-like lectins in health and disease. Carbohydr. Res. 2008, 343, 2050–2056. [Google Scholar] [CrossRef]
- Cagnoni, A.J.; Pérez Sáez, J.M.; Rabinovich, G.A.; Mariño, K.V. Turning-off signaling by siglecs, selectins, and galectins: Chemical inhibition of glycan-dependent interactions in cancer. Front. Oncol. 2016, 6, 109. [Google Scholar] [CrossRef] [Green Version]
- Bärenwaldt, A.; Läubli, H. The sialoglycan-Siglec glyco-immune checkpoint—A target for improving innate and adaptive anti-cancer immunity. Expert Opin. Targets 2019, 23, 839–853. [Google Scholar] [CrossRef]
- Läubli, H.; Varki, A. Sialic acid-binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses. Cell. Mol. Life Sci. 2020, 77, 593–605. [Google Scholar] [CrossRef]
- Sarkar, M.; Reneer, D.V.; Carlyon, J.A. Sialyl-Lewis x-independent infection of human myeloid cells by Anaplasma phagocytophilum strains HZ and HGE1. Infect. Immun. 2007, 75, 5720–5725. [Google Scholar] [CrossRef] [Green Version]
- Seidman, D.; Hebert, K.S.; Truchan, H.K.; Miller, D.P.; Tegels, B.K.; Marconi, R.T.; Carlyon, J.A. Essential domains of Anaplasma phagocytophilum invasins utilized to infect mammalian host cells. PLoS Pathog. 2015, 11, e1004669. [Google Scholar] [CrossRef] [Green Version]
- Maginnis, M.S. Virus-receptor interactions: The key to cellular invasion. J. Mol. Biol. 2018, 430, 2590–2611. [Google Scholar] [CrossRef]
- Kumlin, U.; Olofsson, S.; Dimock, K.; Arnberg, N. Sialic acid tissue distribution and influenza virus tropism. Influenza Other Respir. Viruses 2008, 2, 147–154. [Google Scholar] [CrossRef]
- Connor, R.J.; Kawaoka, Y.; Webster, R.G.; Paulson, J.C. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 1994, 205, 17–23. [Google Scholar] [CrossRef]
- Matrosovich, M.; Tuzikov, A.; Bovin, N.; Gambaryan, A.; Klimov, A.; Castrucci, M.R.; Donatelli, I.; Kawaoka, Y. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol. 2000, 74, 8502–8512. [Google Scholar] [CrossRef] [Green Version]
- Shinya, K.; Ebina, M.; Yamada, S.; Ono, M.; Kasai, N.; Kawaoka, Y. Avian flu: Influenza virus receptors in the human airway. Nature 2006, 440, 435–436. [Google Scholar] [CrossRef]
- Ibricevic, A.; Pekosz, A.; Walter, M.J.; Newby, C.; Battaile, J.T.; Brown, E.G.; Holtzman, M.J.; Brody, S.L. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J. Virol. 2006, 80, 7469–7480. [Google Scholar] [CrossRef] [Green Version]
- Nicholls, J.M.; Chan, M.C.; Chan, W.Y.; Wong, H.K.; Cheung, C.Y.; Kwong, D.L.W.; Wong, M.P.; Chui, W.H.; Poon, L.L.M.; Tsao, S.W.; et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat. Med. 2007, 13, 147–149. [Google Scholar] [CrossRef]
- França, M.; Stallknecht, D.E.; Howerth, E.W. Expression and distribution of sialic acid influenza virus receptors in wild birds. Avian Pathol. 2013, 42, 60–71. [Google Scholar] [CrossRef]
- Connolly, J.L.; Barton, E.S.; Dermody, T.S. Reovirus binding to cell surface sialic acid potentiates virus-induced apoptosis. J. Virol. 2001, 75, 4029–4039. [Google Scholar] [CrossRef] [Green Version]
- Villar, E.; Barroso, I.M. Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: A minireview. Glycoconj. J. 2006, 23, 5–17. [Google Scholar] [CrossRef]
- Gee, G.V.; Dugan, A.S.; Tsomaia, N.; Mierke, D.F.; Atwood, W.J. The role of sialic acid in human polyomavirus infections. Glycoconj. J. 2006, 23, 19–26. [Google Scholar] [CrossRef]
- Zocher, G.; Mistry, N.; Frank, M.; Hähnlein-Schick, I.; Ekström, J.-O.; Arnberg, N.; Stehle, T. A sialic acid binding site in a human picornavirus. PLoS Pathog. 2014, 10, e1004401. [Google Scholar] [CrossRef] [Green Version]
- Chandra, N.; Liu, Y.; Liu, J.X.; Frängsmyr, L.; Wu, N.; Silva, L.M.; Lindström, M.; Chai, W.; Domellöf, F.P.; Feizi, T.; et al. Sulfated glycosaminoglycans as viral decoy receptors for human adenovirus type 37. Viruses 2019, 11, 247. [Google Scholar] [CrossRef] [Green Version]
- Xie, J.; Christiaens, I.; Yang, B.; Trus, I.; Devriendt, B.; Cui, T.; Wei, R.; Nauwynck, H.J. Preferential use of Siglec-1 or Siglec-10 by type 1 and type 2 PRRSV strains to infect PK15S1-CD163 and PK15S10-CD163 cells. Vet. Res. 2018, 49, 67. [Google Scholar] [CrossRef] [Green Version]
- Perez-Zsolt, D.; Martinez-Picado, J.; Izquierdo-Useros, N. When dendritic cells go viral: The role of Siglec-1 in host defense and dissemination of enveloped viruses. Viruses 2019, 12, 8. [Google Scholar] [CrossRef] [Green Version]
- Mikulak, J.; Di Vito, C.; Zaghi, E.; Mavilio, D. Host immune responses in HIV-1 infection: The emerging pathogenic role of Siglecs and their clinical correlates. Front. Immunol. 2017, 8, 314. [Google Scholar] [CrossRef] [Green Version]
- Arokiasamy, S.; Balderstone, M.J.M.; De Rossi, G.; Whiteford, J.R. Syndecan-3 in inflammation and angiogenesis. Front. Immunol. 2020, 10, 3031. [Google Scholar] [CrossRef] [Green Version]
- Mathewson, A.C.; Bishop, A.; Yao, Y.; Kemp, F.; Ren, J.; Chen, H.; Xu, X.; Berkhout, B.; van der Hoek, L.; Jones, I.M.; et al. Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2. J. Gen. Virol. 2008, 89, 2741–2745. [Google Scholar] [CrossRef]
- Lau, S.K.P.; Lau, C.C.Y.; Chan, K.H.; Clara, P.Y.L.; Chen, H.; Jin, D.-Y.; Chan, J.F.W.; Woo, P.C.Y.; Yuen, K.-Y. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: Implications for pathogenesis and treatment. J. Gen. Virol. 2013, 94, 2679–2690. [Google Scholar] [CrossRef]
- Li, Y.; Chen, M.; Cao, H.; Zhu, Y.; Zheng, J.; Zhou, H. Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response. Microbes Infect. 2013, 15, 88–95. [Google Scholar] [CrossRef]
- Sun, X.; Wang, T.; Cai, D.; Hu, Z.; Chen, J.; Liao, H.; Zhi, L.; Wei, H.; Zhang, Z.; Qiu, Y.; et al. Cytokine storm intervention in the early stages of COVID-19 pneumonia. Cytokine Growth Factor. Rev. 2020, 53, 38–42. [Google Scholar] [CrossRef]
- Tisoncik, J.R.; Korth, M.; Simmons, C.P.; Farrar, J.; Martin, T.R.; Katze, M.G. Into the eye of the cytokine storm. Microbiol. Mol. Biol. Rev. 2012, 76, 16–32. [Google Scholar] [CrossRef] [Green Version]
- Li, X.; Geng, M.; Peng, Y.; Meng, L.; Lu, S. Molecular immune pathogenesis and diagnosis of COVID-19. J. Pharm. Anal. 2020, 10, 102–108. [Google Scholar] [CrossRef]
- Molteni, M.; Gemma, S.; Rossetti, C. The role of Toll-like receptor 4 in infectious and noninfectious inflammation. Mediat. Inflamm. 2016, 2016, 6978936. [Google Scholar] [CrossRef] [Green Version]
- Perrin-Cocon, L.; Aublin-Gex, A.; Sestito, S.E.; Shirey, K.A.; Patel, M.C.; André, P.; Blanco, J.C.; Vogel, S.N.; Peri, F.; Lotteau, V. TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection. Sci. Rep. 2017, 7, 40791. [Google Scholar] [CrossRef]
- Thompson, M.R.; Kaminski, J.J.; Kurt-Jones, E.A.; Fitzgerald, K.A. Pattern recognition receptors and the innate immune response to viral infection. Viruses 2011, 3, 920–940. [Google Scholar] [CrossRef] [Green Version]
- Hu, T.; Yu, H.; Lu, M.; Yuan, X. TLR4 and nucleolin influence cell injury, apoptosis and inflammatory factor expression in respiratory syncytial virus-infected N2a neuronal cells. J. Cell. Biochem. 2019, 120, 16206–16218. [Google Scholar] [CrossRef]
- Zeng, Q.; Langereis, M.A.; van Vliet, A.L.; Huizinga, E.G.; de Groot, R.J. Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution. Proc. Natl. Acad. Sci. USA 2008, 105, 9065–9069. [Google Scholar] [CrossRef] [Green Version]
- Hulswit, R.J.G.; Lang, Y.; Bakkers, M.J.G.; Li, W. Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A. Proc. Natl. Acad. Sci. USA 2019, 116, 2681–2690. [Google Scholar] [CrossRef] [Green Version]
- Schultze, B.; Krempl, C.; Ballesteros, M.L.; Shaw, L.; Schauer, R.; Enjuanes, L.; Herrler, G. Transmissible gastroenteritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneuraminic acid) binding activity. J. Virol. 1996, 70, 5634–5637. [Google Scholar] [CrossRef] [Green Version]
- Cui, T.; Theuns, S.; Xie, J.; Van den Broeck, W.; Nauwynck, H.J. Role of porcine aminopeptidase N and sialic acids in porcine coronavirus infections in primary porcine enterocytes. Viruses 2020, 12, 402. [Google Scholar] [CrossRef] [Green Version]
- Wong, A.H.M.; Tomlinson, A.C.A.; Zhou, D.; Satkunarajah, M.; Chen, K.; Sharon, C.; Desforges, M.; Talbot, P.J.; Rini, J.M. Receptor-binding loops in alphacoronavirus adaptation and evolution. Nat. Commun. 2017, 8, 1735. [Google Scholar] [CrossRef]
- Eckerle, I.; Müller, M.A.; Kallies, S.; Gotthardt, D.N.; Drosten, C. In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection. Virol. J. 2013, 10, 359. [Google Scholar] [CrossRef] [Green Version]
- Alsolamy, S.; Arabi, Y.M. Infection with Middle East respiratory syndrome coronavirus. Can. J. Respir. 2015, 51, 102. [Google Scholar]
- Gu, J.; Gong, E.; Zhang, B.; Zheng, J.; Gao, Z.; Zhong, Y.; Zou, W.; Zhan, J.; Wang, S.; Xie, Z.; et al. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 2005, 202, 415–424. [Google Scholar] [CrossRef]
- Belouzard, S.; Chu, V.C.; Whittaker, G.R. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc. Natl. Acad. Sci. USA 2009, 106, 5871–5876. [Google Scholar] [CrossRef] [Green Version]
- Shirato, K.; Kawase, M.; Matsuyama, S. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. J. Virol. 2013, 87, 12552–12561. [Google Scholar] [CrossRef] [Green Version]
- Hoffmann, M.; Kleine-Weber, H.; Pöhlmann, S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cell. Mol. Cell. 2020, 78, 779–784. [Google Scholar] [CrossRef]
- Chan, P.K.; To, K.F.; Lo, A.W.; Cheung, J.L.K.; Chu, I.; Au, F.W.L.; Tong, J.H.M.; Tam, J.S.; Sung, J.J.Y.; Ng, H.-K. Persistent infection of SARS coronavirus in colonic cells in vitro. J. Med. Virol. 2004, 74, 1–7. [Google Scholar] [CrossRef]
- Ma, D.; Chen, C.B.; Jhanji, V.; Yuan, X.-L.; Liang, J.-J.; Huang, Y.; Cen, L.-P.; Ng, T.K. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea. Eye 2020, 34, 1–8. [Google Scholar] [CrossRef]
- Ou, X.; Liu, Y.; Lei, X.; Li, P.; Mi, D.; Ren, L.; Guo, L.; Guo, R.; Chen, T.; Hu, J.; et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun. 2020, 11, 1620. [Google Scholar] [CrossRef] [Green Version]
- Li, W.; Hulswit, R.J.G.; Widjaja, I.; Stalin Raj, V.; McBride, R.; Peng, W.; Widagdo, W.; Alejandra Tortorici, M.; van Dieren, B.; Lang, Y.; et al. Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein. Proc. Natl. Acad. Sci. USA 2017, 114, E8508–E8517. [Google Scholar] [CrossRef] [Green Version]
- Huang, X.; Dong, W.; Milewska, A.; Golda, A.; Qi, Y.; Zhu, Q.K.; Marasco, W.A.; Baric, R.S.; Sims, A.C.; Pyrc, K.; et al. Human coronavirus HKU1 spike protein uses O-acetylated sialic acid as an attachment receptor determinant and employs hemagglutinin-esterase protein as a receptor-destroying enzyme. J. Virol. 2015, 89, 7202–7213. [Google Scholar] [CrossRef] [Green Version]
- Petrosillo, N.; Viceconte, G.; Ergonul, O.; Ippolito, G.; Petersen, E. COVID-19, SARS and MERS: Are they closely related? Clin. Microbiol. Infect. 2020, 26, 729–734. [Google Scholar] [CrossRef]
- Ceccarelli, M.; Berretta, M.; Venanzi Rullo, E.; Nunnari, G.; Cacopardo, B. Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? Eur. Rev. Med. Pharm. Sci. 2020, 24, 2781–2783. [Google Scholar] [CrossRef]
- Wang, H.; Li, X.; Li, T.; Zhang, S.; Wang, L.; Wu, X.; Liu, J. The genetic sequence, origin, and diagnosis of SARS-CoV-2. Eur. J. Clin. Microbiol. Infect. Dis. 2020, 39, 1629–1635. [Google Scholar] [CrossRef]
- Wan, Y.; Shang, J.; Graham, R.; Baric, R.S.; Li, F. Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. J. Virol. 2020, 94, e00127-20. [Google Scholar] [CrossRef] [Green Version]
- Xia, S.; Liu, M.; Wang, C.; Xu, W.; Lan, Q.; Feng, S.; Qi, F.; Bao, L.; Du, L.; Liu, S.; et al. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. Cell. Res. 2020, 30, 343–355. [Google Scholar] [CrossRef] [Green Version]
- Al-Tawfiq, J.A. Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19). Travel. Med. Infect. Dis. 2020, 35, 101608. [Google Scholar] [CrossRef]
- Fantini, J.; Di Scala, C.; Chahinian, H.; Yahi, N. Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. Int. J. Antimicrob. Agents 2020, 55, 105960. [Google Scholar] [CrossRef]
- Vandelli, A.; Monti, M.; Milanetti, E.; Rupert, J.; Zacco, E.; Bechara, E.; Ponti, R.D.; Tartaglia, G.G. Structural analysis of SARS-CoV-2 and predictions of the human interactome. bioRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Milanetti, E.; Miotto, M.; Di Rienzo, L.; Monti, M.; Gosti, G.; Ruocco, G. In-Silico evidence for two receptors based strategy of SARS-CoV-2. bioRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
- Creager, H.M.; Kumar, A.; Zeng, H.; Maines, T.R.; Tumpey, T.M.; Belser, J.A. Infection and replication of influenza virus at the ocular surface. J. Virol. 2018, 92, e02192-17. [Google Scholar] [CrossRef] [Green Version]
- Loon, S.C.; Teoh, S.C.; Oon, L.L.; Se-Thoe, S.-Y.; Ling, A.-E.; Leo, Y.-S.; Leong, H.-N. The severe acute respiratory syndrome coronavirus in tears. Br. J. Ophthalmol. 2004, 88, 861–863. [Google Scholar] [CrossRef] [Green Version]
- Colavita, F.; Lapa, D.; Carletti, F.; Lalle, E.; Bordi, L.; Marsella, P.; Nicastri, E.; Bevilacqua, N.; Giancola, M.L.; Corpolongo, A.; et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann. Intern. Med. 2020, 173, 242–243. [Google Scholar] [CrossRef]
- World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19); 14–20 February 2020; WHO: Geneva, Switzerland, 2020. [Google Scholar]
- Chappey, B.; Beyssen, B.; Foos, E.; Ledru, F.; Guermonprez, J.L.; Gaux, J.C.; Myara, I. Sialic acid content of LDL in coronary artery disease: No evidence of desialylation in subjects with coronary stenosis and increased levels in subjects with extensive atherosclerosis and acute myocardial infarction: Relation between desialylation and in vitro peroxidation. Arter. Thromb. Vasc. Biol. 1998, 18, 876–883. [Google Scholar]
- Nigam, P.K.; Narain, V.S.; Kumar, A. Sialic acid in cardiovascular diseases. Indian J. Clin. Biochem. 2006, 21, 54–61. [Google Scholar] [CrossRef] [Green Version]
- Gopaul, K.P.; Crook, M.A. Sialic acid: A novel marker of cardiovascular disease? Clin. Biochem. 2006, 39, 667–681. [Google Scholar] [CrossRef]
- Zhang, C.; Chen, J.; Liu, Y.; Xu, D. Sialic acid metabolism as a potential therapeutic target of atherosclerosis. Lipids Health Dis. 2019, 18, 173. [Google Scholar] [CrossRef] [Green Version]
- Zhang, Y.; Zheng, Y.; Li, J.; Nie, L.; Hu, Y.; Wang, F.; Liu, H.; Fernandes, S.M.; Zhong, Q.; Li, X.; et al. Immunoregulatory Siglec ligands are abundant in human and mouse aorta and are up-regulated by high glucose. Life Sci. 2019, 216, 189–199. [Google Scholar] [CrossRef]
- Kirkeby, S.; Jensen, N.E.; Mandel, U.; Poulsen, S.S. Asthma induction in mice leads to appearance of alpha2-3- and alpha2-6-linked sialic acid residues in respiratory goblet-like cells. Virchows Arch. 2008, 453, 283–290. [Google Scholar] [CrossRef]
- Rathod, S.; Shori, T.; Sarda, T.S.; Raj, A.; Jadhav, P. Comparative analysis of salivary sialic acid levels in patients with chronic obstructive pulmonary disease and chronic periodontitis patients: A biochemical study. Indian J. Dent. Res. 2018, 29, 22–25. [Google Scholar] [CrossRef]
- Guo, F.R. Active smoking is associated with severity of coronavirus disease 2019 (COVID-19): An update of a meta-analysis. Tob. Induc. Dis. 2020, 18, 37. [Google Scholar] [CrossRef]
- Vardavas, C.I.; Nikitara, K. COVID-19 and smoking: A systematic review of the evidence. Tob. Induc. Dis. 2020, 18, 20. [Google Scholar] [CrossRef]
- Liu, W.; Tao, Z.W.; Wang, L.; Yuan, M.-L.; Liu, K.; Zhou, L.; Wei, S.; Deng, Y.; Liu, J.; Liu, H.-G.; et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin. Med. J. 2020, 133, 1032–1038. [Google Scholar] [CrossRef]
- Wielgat, P.; Trofimiuk, E.; Czarnomysy, R.; Holownia, A.; Braszko, J.J. Sialylation pattern in lung epithelial cell line and Siglecs expression in monocytic THP-1 cells as cellular indicators of cigarette smoke-induced pathology in vitro. Exp. Lung Res. 2018, 44, 167–177. [Google Scholar] [CrossRef]
- Leung, J.M.; Yang, C.X.; Tam, A.; Shaipanich, T.; Hackett, T.-L.; Singhera, G.K.; Dorscheid, D.R.; Sin, D.D. ACE-2 expression in the small airway epithelia of smokers and COPD patients: Implications for COVID-19. Eur. Respir. J. 2020, 55, 2000688. [Google Scholar] [CrossRef] [Green Version]
- Reghunathan, R.; Jayapal, M.; Hsu, L.Y.; Chng, H.-H.; Tai, D.; Leung, B.P.; Melendez, A.J. Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunol. 2005, 6, 2. [Google Scholar] [CrossRef] [Green Version]
- Frieman, M.; Heise, M.; Baric, R. SARS coronavirus and innate immunity. Virus Res. 2008, 133, 101–112. [Google Scholar] [CrossRef]
- Varki, A.; Angata, T. Siglecs—The major subfamily of I-type lectins. Glycobiology 2006, 16, 1R–27R. [Google Scholar] [CrossRef] [Green Version]
- Teuton, J.R.; Brandt, C.R. Sialic acid on herpes simplex virus type 1 envelope glycoproteins is required for efficient infection of cells. J. Virol. 2007, 81, 3731–3739. [Google Scholar] [CrossRef] [Green Version]
- Vanderheijden, N.; Delputte, P.L.; Favoreel, H.W.; Vandekerckhove, J.; Van Damme, J.; van Woensel, P.A.; Nauwynck, H.J. Involvement of sialoadhesin in entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages. J. Virol. 2003, 77, 8207–8215. [Google Scholar] [CrossRef] [Green Version]
- Delputte, P.L.; Nauwynck, H.J. Porcine arterivirus infection of alveolar macrophages is mediated by sialic acid on the virus. J. Virol. 2004, 78, 8094–8101. [Google Scholar] [CrossRef] [Green Version]
- Zheng, Y.; Ma, X.; Su, D.; Zhang, Y.; Yu, L.; Jiang, F.; Zhou, X.; Feng, Y.; Ma, F. The roles of Siglec7 and Siglec9 on natural killer cells in virus infection and tumour progression. J. Immunol. Res. 2020, 2020, 6243819. [Google Scholar] [CrossRef]
- Zhao, D.; Jiang, X.; Xu, Y.; Yang, H.; Gao, D.; Li, X.; Gao, L.; Ma, C.; Liang, X. Decreased Siglec-9 expression on natural killer cell subset associated with persistent HBV replication. Front. Immunol. 2018, 9, 1124. [Google Scholar] [CrossRef] [Green Version]
- Yamanaka, M.; Kato, Y.; Angata, T.; Narimatsu, H. Deletion polymorphism of SIGLEC14 and its functional implications. Glycobiology 2009, 19, 841–846. [Google Scholar] [CrossRef]
- Tsai, C.M.; Riestra, A.M.; Ali, S.R.; Fong, J.J.; Liu, J.Z.; Hughes, G.; Varki, A.; Nizet, V. Siglec-14 enhances NLRP3-inflammasome activation in macrophages. J. Innate. Immun. 2019, 1–11. [Google Scholar] [CrossRef]
- Chang, Y.C.; Nizet, V. The interplay between Siglecs and sialylated pathogens. Glycobiology 2014, 24, 818–825. [Google Scholar] [CrossRef] [Green Version]
- Ali, S.R.; Fong, J.J.; Carlin, A.F.; Busch, T.D.; Linden, R.; Angata, T.; Areschoung, T.; Parast, M.; Varki, N.M.; Murray, J.C.; et al. Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus. J. Exp. Med. 2014, 211, 1231–1242. [Google Scholar] [CrossRef]
- Auyeung, T.W.; Lee, J.S.; Lai, W.K.; Choi, C.H.; Lee, H.K.; Lee, J.S.; Li, P.C.; Lok, K.H.; Ng, Y.Y.; Ming, W.W.; et al. The use of corticosteroid as treatment in SARS was associated with adverse outcomes: A retrospective cohort study. J. Infect. 2005, 51, 98–102. [Google Scholar] [CrossRef]
- Wielgat, P.; Mroz, R.M.; Stasiak-Barmuta, A.; Szepiel, P.; Chyczewska, E.; Braszko, J.J.; Holownia, A. Inhaled corticosteroids increase siglec-5/14 expression in sputum cells of COPD patients. Adv. Exp. Med. Biol. 2015, 839, 1–5. [Google Scholar] [CrossRef]
- Zeng, Z.; Li, M.; Wang, M.; Wu, X.; Li, Q.; Ning, Q.; Zhao, J.; Xu, Y.; Xie, J. Increased expression of Siglec-9 in chronic obstructive pulmonary disease. Sci. Rep. 2017, 7, 10116. [Google Scholar] [CrossRef] [Green Version]
- Singh, A.K.; Singh, A.; Shaikh, A.; Singh, R.; Misra, A. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Diabetes Metab. Syndr. 2020, 14, 241–246. [Google Scholar] [CrossRef]
- Liu, J.; Cao, R.; Xu, M.; Wang, X.; Zhang, H.; Hu, H.; Li, Y.; Hu, Z.; Zhong, W.; Wang, M. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell. Discov. 2020, 6, 16. [Google Scholar] [CrossRef] [Green Version]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Wielgat, P.; Rogowski, K.; Godlewska, K.; Car, H. Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects. Cells 2020, 9, 1963. https://doi.org/10.3390/cells9091963
Wielgat P, Rogowski K, Godlewska K, Car H. Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects. Cells. 2020; 9(9):1963. https://doi.org/10.3390/cells9091963
Chicago/Turabian StyleWielgat, Przemyslaw, Karol Rogowski, Katarzyna Godlewska, and Halina Car. 2020. "Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects" Cells 9, no. 9: 1963. https://doi.org/10.3390/cells9091963